NFKB1 and rheumatoid arthritis: Here, we identify ALOX5 as a previously unrecognized direct target of celastrol and further demonstrate that the ALOX5–macrophage axis drives bone destruction in rheumatoid arthritis through a novel transcriptional mechanism involving NF-κB/RELA.